Biotech news

Reset all filters
Geography
Company
Refine search
Profit is at the heart of every IPR, says Kyle Bass
Americas
Hedge fund manager Kyle Bass has fired a response to a motion filed by biotechnology company Celgene seeking to sanction him over “abusive” patent challenges, stating that profit motive is at the centre of every inter partes review filing.   13 August 2015
London branch of UPC revealed
Pharma
The UK Intellectual Property Office has revealed the location for the country’s central and local divisions of the forthcoming Unified Patent Court.   12 August 2015
Regeneron defeated in GM mouse patent row
Americas
A US court has ruled that biotechnology company Regeneron engaged in “inequitable conduct” after finding that it withheld information from a patent application for a genetically modified mouse.   11 August 2015
Americas
The European Commission has approved US pharmaceutical company Pfizer’s $17 billion acquisition of Hospira, a move that will see Pfizer acquire the drugs company’s biosimilar portfolio.   6 August 2015
Americas
A Brazilian court has confirmed that a eucalyptus breed produced by biotechnology company Eldorado Brasil Celulose is genetically identical to pulp producer Fibria Celulose’s own cultivar product VTO2.   4 August 2015
Americas
The US Court of Appeals for the Federal Circuit’s decision in Amgen v Sandoz is what the biosimilar industry would have been hoping for but clarity is lacking in several areas, lawyers have told LSIPR.   23 July 2015
Americas
Law firm Hughes Hubbard & Reed has expanded its intellectual property practice by hiring Patrice Jean as a partner.   23 July 2015
Americas
Biopharma parties thinking about challenging a patent via an inter partes review should be aware that there are significant differences between district court and IPR practice, as Tasha Francis and Dorothy Whelan of Fish & Richardson explain.   23 July 2015
Pharma
A new parliamentary group has been created to raise awareness of and help to develop the life sciences industry in the UK.   21 July 2015
Americas
The US Court of Appeals for the Federal Circuit has upheld a ruling from the Patent Trial and Appeal Board that invalidated three patents owned by Columbia University covering DNA sequencing.   20 July 2015